AUTISM

AUTISM

July 29, 2012

Ministry of Health Approves Brainsway Clinical Trial for Autism

JERUSALEM (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to test the efficacy of its Deep TMS (Transcranial Magnetic Stimulation) system as a treatment for autism in children with low functionality levels. The trial, which will begin in the near future, will be conducted at Hadassah Medical Center Ein Kerem in Jerusalem and will include 40 subjects.

Uzi Sofer, Brainsway's Chief Executive Officer, commented, "While Brainsway has previously received approval for carrying out a study of our Deep TMS system together with Harvard Medical School in the United States on children with epilepsy, this will be our first clinical trial in a pediatric population in Israel." READ MORE >>

Press Release: GlobeNewswire



HELP US SPREAD GLOBAL AUTISM AWARENESS*

SECURE DONATION via PayPal

No comments:

Post a Comment